Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Infect Dis ; 225(6): 1021-1031, 2022 03 15.
Article de Anglais | MEDLINE | ID: mdl-34791324

RÉSUMÉ

BACKGROUND: Pneumococcal vaccination is recommended in people with HIV, prioritizing PCV. We compared the immunogenicity of PCV-10 and PPV-23 administered antepartum or postpartum. METHODS: This double-blind study randomized 346 pregnant women with HIV on antiretrovirals to PCV-10, PPV-23, or placebo at 14-34 weeks gestational age. Women who received placebo antepartum were randomized at 24 weeks postpartum to PCV-10 or PPV-23. Antibodies against 7 serotypes common to both vaccines and 1 serotype only in PPV-23 were measured by ELISA/chemiluminescence; B- and T-cell responses to serotype 1 by FLUOROSPOT; and plasma cytokines/chemokines by chemiluminescence. RESULTS: Antibody responses were higher after postpartum versus antepartum vaccination. PCV-10 generated lower antibody levels than PPV-23 against 4 and higher against 1 of 7 common serotypes. Additional factors associated with high postvaccination antibody concentrations were high prevaccination antibody concentrations and CD4+ cells; low CD8+ cells and plasma HIV RNA; and several plasma cytokines/chemokines. Serotype 1 B- and T-cell memory did not increase after vaccination. CONCLUSIONS: Antepartum immunization generated suboptimal antibody responses, suggesting that postpartum booster doses may be beneficial and warrant further studies. Considering that PCV-10 and PPV-23 had similar immunogenicity, but PPV-23 covered more serotypes, use of PPV-23 may be prioritized in women with HIV on antiretroviral therapy. CLINICAL TRAILS REGISTRATION: NCT02717494.


Sujet(s)
Infections à VIH , Infections à pneumocoques , Anticorps antibactériens , Cytokines , Femelle , Infections à VIH/complications , Humains , Infections à pneumocoques/prévention et contrôle , Vaccins antipneumococciques , Polyosides , Période du postpartum , Grossesse , Vaccination , Vaccins conjugués
2.
Clin Infect Dis ; 65(4): 687-690, 2017 08 15.
Article de Anglais | MEDLINE | ID: mdl-28444144

RÉSUMÉ

We report 2 fatal cases of congenital Zika virus (ZIKV) infection. Brain anomalies, including atrophy of the cerebral cortex and brainstem, and cerebellar aplasia were observed. The spinal cord showed architectural distortion, severe neuronal loss, and microcalcifications. The ZIKV proteins and flavivirus-like particles were detected in cytoplasm of spinal neurons, and spinal cord samples were positive for ZIKV RNA.


Sujet(s)
Complications infectieuses de la grossesse , Maladies de la moelle épinière , Moelle spinale/malformations , Infection par le virus Zika , Virus Zika , Issue fatale , Femelle , Humains , Nouveau-né , Mâle , Grossesse , Complications infectieuses de la grossesse/anatomopathologie , Complications infectieuses de la grossesse/virologie , Maladies de la moelle épinière/congénital , Maladies de la moelle épinière/anatomopathologie , Maladies de la moelle épinière/virologie , Infection par le virus Zika/congénital , Infection par le virus Zika/anatomopathologie , Infection par le virus Zika/virologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE